Brian Imbiakha

A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic

Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion et al. · Nature · 2022 · 222 citations · Full text

Effect of Perfluorooctanesulfonic acid (PFOS) on immune cell development and function in mice

Luisa Torres, Amie Redko, Candice Limper et al. · Immunology Letters · 2021 · 24 citations · Full text

Inflammation, Anti-inflammatory, Autoimmune Disease +14

Multivalent viral particles elicit safe and efficient immunoprotection against Nipah Hendra and Ebola viruses

Duncan G. Ithinji, David W. Buchholz, Shahrzad Ezzatpour et al. · npj Vaccines · 2022 · 23 citations · Full text

Vaccination, Cross-protection, Vaccine Development +14

Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5

Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz et al. · Science Advances · 2023 · 22 citations · Full text

A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in mice

Tirosh Shapira, I. Abrrey Monreal, Sébastien P. Dion et al. · 2021 · 16 citations · Full text